AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor

AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...

Israel stocks mixed; Teva drug advances; Ceragon jumps - MarketWatch

Israel stocks mixed; Teva drug advances; Ceragon jumps
MarketWatch
On Friday, the company's shares traded on Wall Street jumped nearly 13% in after-hours trading. The Israeli business daily Globes speculated that the stock ...

and more »

Israel stocks mixed; Teva drug advances; Ceragon jumps - MarketWatch

Israel stocks mixed; Teva drug advances; Ceragon jumps
MarketWatch
On Friday, the company's shares traded on Wall Street jumped nearly 13% in after-hours trading. The Israeli business daily Globes speculated that the stock ...

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor

AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor

AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...

Israel stocks mixed; Teva drug advances; Ceragon jumps - MarketWatch

Israel stocks mixed; Teva drug advances; Ceragon jumps
MarketWatch
On Friday, the company's shares traded on Wall Street jumped nearly 13% in after-hours trading. The Israeli business daily Globes speculated that the stock ...

and more »

Israel stocks mixed; Teva drug advances; Ceragon jumps - MarketWatch

Israel stocks mixed; Teva drug advances; Ceragon jumps
MarketWatch
On Friday, the company's shares traded on Wall Street jumped nearly 13% in after-hours trading. The Israeli business daily Globes speculated that the stock ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor

AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor

AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...

Israel stocks mixed; Teva drug advances; Ceragon jumps - MarketWatch

Israel stocks mixed; Teva drug advances; Ceragon jumps
MarketWatch
On Friday, the company's shares traded on Wall Street jumped nearly 13% in after-hours trading. The Israeli business daily Globes speculated that the stock ...

and more »

Jim Cramer mention boosts Ceragon shares - Globes

Jim Cramer mention boosts Ceragon shares
Globes
In after-hours trading on Nasdaq the share jumped 12.5%. On the TASE the share was up 9.42% to NIS 29.50 by early afternoon trading today. ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor

AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...

Regeneron halts Phase 3 trial of cancer drug - Albany Times Union

Regeneron halts Phase 3 trial of cancer drug
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...

and more »

Regeneron halts Phase 3 trial of cancer drug - Albany Times Union

Regeneron halts Phase 3 trial of cancer drug
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor

AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...

Regeneron halts Phase 3 trial of cancer drug - Albany Times Union

Regeneron halts Phase 3 trial of cancer drug
Albany Times Union
In after-hours trading, shares were off another 88 cents to $21. Trading in the shares had been halted before the announcement. WATERVLIET -- The US Senate ...

and more »

AFTER THE BELL-Regeneron falls after drug-trial halt - Interactive Investor

AFTER THE BELL-Regeneron falls after drug-trial halt
Interactive Investor
NEW YORK, Sept 11 (Reuters) - Regeneron Pharmaceuticals Inc shares dropped 3.9 percent to $21.03 in extended trade on Friday after the company said it ...